Engaging Research to Achieve Cancer Care Equity
asco quality care symposium
Racial Disparities in Performance Status
A new study by ConcertAI based on patient-reported outcomes makes another compelling case for addressing disparities in treatment outcomes and racially biased access to clinical trials – and for why a new research focus is imperative.See Full Study
Retrospective Study of Self-Assessed Performance Status (ECOG)
- Clinical trials lack adequate number of racial minorities.
- Performance status often a criterion for clinical research.
- Poor performance status can exclude patients from clinical trial participation.
Patient in Study
- 55.4% White
- 38.0% Black
Black patients overall reported higher average ECOG scores and greater difficulty performing daily functions than White patients.
Patients reporting not being able to take care of themselves
Significant racial disparities exist in performance status at an initial visit to an oncology clinic and, for Black patients, could mean:
• Lower quality medical care pre-diagnosis
• Poorer outcomes
• Exclusion from clinical trials
ERACE Research Award
Announcing Award Recipients
We are pleased to announce that two grant applications have been accepted for the ERACE Research Award. The grant includes access to ERACE’s Real-world data (RWD) patient registry in support of cancer disparity research.
2021 ASCO Annual Meeting
Read the latest research focused on racial differences in demographics, diagnoses and symptoms among oncology patients.
Assessment of differences in demographic characteristics and clinical diagnoses among black and white oncology patients with COVIDRead More
Differences by race in patient-reported symptoms during chemotherapy among women with early-stage, hormone receptor-positive breast cancerRead More
See more ConcertAI research published at the 2021 ASCO Annual Meeting.Read More